Biotechnologies - into life

Found results: 262

Biotechnologies - into life

Neuroscience and public investment

In 2005, the Department of Neurodynamics and Neurobiology was opened at Nizhny Novgorod State University. When the university received a large grant within the framework of the national project “Education”, an amount equivalent to one million euros was allocated to our department. With this money, we are forming an educational neuroscience laboratory, which will be equipped with modern equipment, which currently has no analogues in Russia.

11.07.2008
Biotechnologies - into life

How Danone Turns Bacteria into Bucks

The main talent of the French is the transformation of bacteria into bucks! They used the most advanced scientific developments to identify microorganisms that contribute to improving a person's well-being and even the freshness of his appearance.

11.07.2008
Biotechnologies - into life

Biotechnology on lease

The effectiveness of leasing becomes obvious if the process of obtaining a certain resource is decomposed into components.

11.07.2008
Biotechnologies - into life

Business Angel for sliced DNA

To understand the revolutionary nature of the new technology, it is enough to give a simple example: to measure the concentration of an antibiotic in the blood by traditional methods, it will take two days, and the use of abnormal optical activity of DNA scraps turned into a liquid crystal will reduce this time to ten minutes.

11.07.2008
Biotechnologies - into life

Russian-European biotechnologies

The winners of joint scientific projects in which scientists from Russia and the European Union participated for the first time were named. Three of the four projects relate to biotechnology.

19.06.2008
Biotechnologies - into life

Show me your DNA

Established in 1993, the DNA Technology company was involved in the operation of a landmark world discovery and today sells DNA analysis equipment for $ 10 million a year.

16.06.2008
Biotechnologies - into life

Pharma 2020: from generics to innovative drugs

According to the authors of Pharma 2020, the growth of the innovative component of the industry can be ensured only if the volume of investments in it reaches about $ 200 million per year.

10.06.2008
Biotechnologies - into life

Scientists from Pushchino revive domestic pharmaceuticals

The Security Council of the Russian Federation instructed the government to develop and adopt a strategy for the development of the domestic pharmaceutical industry by October 1. What can be the contribution of Russian scientists to the implementation of this plan?

29.05.2008
Biotechnologies - into life

Problems of domestic pharmaceuticals and possible solutions

The pharmaceutical industry in the modern economy is a kind of litmus test showing the level of its innovative development. We are talking with Andrey Ivashchenko, the project manager of the ChemRar Central Research Center, about what problems there are in the domestic pharmaceutical industry and about possible ways to solve them.

26.05.2008
Biotechnologies - into life

UK biotechnology: the market will not forgive the lag

The UK's contribution to the improvement of medical technologies has always been huge. But from the point of view of one of the most successful entrepreneurs in the field of biotechnology, this industry is in serious danger.

16.05.2008
Biotechnologies - into life

Russian pharmaceutical industry in 2006

The dynamics of ratings conducted according to the state statistical reports of about 90 enterprises of the Russian pharmaceutical industry is considered.

13.05.2008
Biotechnologies - into life

Diagnose cancer by clones

The Laboratory of Viral RNA Biochemistry at the Protein Institute is developing technologies for early cancer diagnosis based on the method of molecular cloning.

06.05.2008
Biotechnologies - into life

At the membrane level

The Institute of Bioorganic Chemistry of the Russian Academy of Sciences has been working on membrane proteins since the mid-1970s. During the years of perestroika, most of the scientific groups actually broke up. And only in the laboratory of structural biology, the work related to membrane proteins, despite all the difficulties, continued.

16.04.2008
Biotechnologies - into life

PHARMA-2020. Shaping the future of the pharmaceutical industry

Currently, the global pharmaceutical industry has reached a precedent level of changes. And the future belongs to those pharmaceutical companies that will learn to save money: first of all, the patient, and secondly, their own

15.04.2008
Biotechnologies - into life

Away from the "big pharma"

We are implicitly given to understand that all efforts to create new original Russian drugs are generally meaningless, because everything is already there, everything is invented, everything can be bought on the world market.

31.03.2008
Biotechnologies - into life

State vitamin deficiency

For too long, the fact of technical backwardness, the wretchedness of hardware equipment, unprofitable volumes of unit capacity, etc., plus the notorious residual financing, was ignored. Ignoring these facts exacerbated the consequences – the collapse of domestic ascorbic acid production.

26.03.2008